Skip to main content
Tech.euFundingExplorerBeta

Tubulis Technologies

Tubulis Technologies generates uniquely matched protein-drug conjugates.

Tubulis Technologies has raised €379M across 3 funding rounds from 18 investors, most recently a Series C round in Oct 2025. Based in Munich, Germany; founded 2019; active in Healthtech. Data as of 28 Oct 2026.

Munich, GermanyFounded 2019tubulis.com ↗
Total raised
€379M
€378,700,000
Funding rounds
3
Investors
18
distinct backers
Active since
2020-07
latest 2025-10

Funding by year

EUR raised per year
Tubulis Technologies — funding by year — interactive chart.
Data table
Tubulis Technologies — funding by year
2020€11M
2022€60M
2025€308M

Signals

High confidence
Raise-next likelihood76
base rate 50% for Series C
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood30
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 7y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData